Biotech startup Anatomi, based on UMN research, is developing a technology that produces human neurons from stem cells at a faster rate than previous technologies.
Anatomi was among the first graduates of Discovery Launchpad, a startup incubator and coaching program from the University of Minnesota’s Office of Technology Commercialization. Walsh and Truong spent about a year in the program after Anatomi’s June 2018 launch. Mary MacCarthy, a Discovery Launchpad adviser, said Anatomi “is poised for some breakout moves” that will garner even more notice locally and nationally.
“They have a really nice value proposition in that they can provide a service faster than anybody else has been able to crack or achieve through science,” MacCarthy said. “While they’re not diagnosing anything or curing anything, they’re helping companies develop cures faster than anybody else can. I’d say there is a lot of opportunity for them to continue to grow.”
Read the full story in Finance & Commerce.